Reducing the Health Burden of HPV Infection Through Vaccination
Author:
Open Access
- 30 January 2006
- journal article
- research article
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2006 (1) , 83084
Abstract
Human papillomavirus (HPV), a sexually transmitted infection and the etiologic cause of genital warts and cervical cancer, is highly prevalent in sexually active men and women. Although cervical screening procedures have significantly reduced the disease burden associated with HPV infection, they are expensive and abnormal results cause significant emotional distress. Therefore, prevention may be an effective strategy for reducing the economic, psychosocial, and disease burden of HPV infection. Multivalent vaccines are now in clinical development. A bivalent vaccine that protects against HPV 16 and 18, and a quadrivalent vaccine which protects against HPV types 6, 11, 16, and 18, have been shown to significantly reduce the occurrence of incident and persistent HPV infections in phase 2 clinical trials; phase 3 trials are currently underway. HPV vaccines will be most effective when administered prior to initiation of sexual activity, and vaccination campaigns should aggressively target preadolescent and adolescent populations.Keywords
This publication has 41 references indexed in Scilit:
- A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccineVaccine, 2004
- Dose-ranging studies of the safety and immunogenicity of human papillomavirus Type 11 and Type 16 virus-like particle candidate vaccines in young healthy womenVaccine, 2004
- Delivering on the promise: HPV vaccines and cervical cancerNature Reviews Microbiology, 2004
- Adults' Knowledge and Behaviors Related to Human Papillomavirus InfectionThe Journal of the American Board of Family Medicine, 2004
- The Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000Perspectives on Sexual and Reproductive Health, 2004
- Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000Perspectives on Sexual and Reproductive Health, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Determinants of Genital Human Papillomavirus Detection in a US PopulationThe Journal of Infectious Diseases, 2001
- Knowledge about human papillomavirus among adolescentsObstetrics & Gynecology, 2000
- Declining Prevalence of Cervicovaginal Human Papillomavirus Infection With Age Is Independent of Other Risk FactorsSexually Transmitted Diseases, 1996